Offering End-to-End Solutions
WuXi Vaccines, a subsidiary of WuXi Biologics, focuses on vaccine development and manufacturing. With multiple commercial vaccines manufactured at globally GMP-certified facilities, and over 38 projects in development, WuXi Vaccines brings a level of expertise, experience and state-of-the-art facilities to enable your project to be conducted right the first time. As an industry-leading CDMO, we provide world-class integrated development and manufacturing platforms to expedite your vaccine to the clinic and the market.
WuXi Vaccines views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the vaccines CDMO sector. Our facilities use next-generation biomanufacturing technologies and clean energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, enhancing our commitment to sustainability.
Regulatory Inspections Passed
Major Observation in EMA PAI
Million Doses Delivered
Countries Served in the Fight Against COVID-19
To be an enabler for global vaccines development and manufacturing by applying the best integrated open technology platforms.
By leveraging our technical strengths, premium quality in CMC & Regulatory capabilities, technical platforms and manufacture facilities, we provide a truly end-to-end service from vaccine development to scaled-up and commercial manufacturing to any global customer.
WuXi Vaccines leverages capabilities, capacities, and experienced staff across our global network through WuXi Biologics, to provide partners with end-to-end development and manufacturing services tailored to their innovative vaccine projects. In addition to the extensive resources available to us across China, US and Europe for clinical and commercial supply, we are establishing a global network of dedicated facilities for vaccines.
WuXi Vaccines Dundalk Site is located mid-way between Dublin and Belfast, less than an hour’s drive from Ireland’s two largest cities. The site is a greenfield development of an integrated vaccine manufacturing facility to be used exclusively as part of a 20-year vaccine manufacturing contract with a global vaccine leader, valued at approximately USD $3 billion.
Dundalk site is equipped with drug substance manufacturing (DS), drug product manufacturing (DP), Manufacture Science and Technology Labs (MS&T) as well as Quality Control labs (QC).
The QC potency lab became operational in July 2020 and received the GMP certificate from Ireland Health Products Regulatory Authority (HPRA) in July 2022. Following the mechanical completion of the main manufacturing facility in October 2022, steps are underway toward commissioning, qualification and validation (CQV), tech transfer (TT), and process performance qualification (PPQ), all leading towards the launch of a great innovative vaccine.
WuXi Vaccines Suzhou Site is located in Suzhou Industrial Park with 20 minutes train journey to Shanghai. The 8,500-square-metre facility includes multiple 250L, 500L and 1000L single-use bioreactors as well as sterile drug-product manufacturing lines. The facility will be ready for GMP production in 2023. The site will become a new node within WuXi Vaccines' global network and after renovation will provide industry-leading vaccine development and GMP manufacturing services for our global partners.
Integrity, Dedication, Working Together & Sharing Success
Exceed customers’ expectations, maximize the value for our customers, and win customers’ loyalty with a 100% customer retention rate.
Take the initiative to promote a positive work environment where doing the right thing is the standard. Be positive and enthusiastic, approach challenges with energy and optimism.
Pursue focus and expertise, and optimize processes in order to deliver excellent results. Relentlessly drive learning, accumulation, improvement and innovation.
Drive effective execution of each project and objective, focusing on solutions and results.
Engage in collaboration and mutual development with an open and win-win mindset by sharing resources and leveraging the complementary advantages of each.
Demonstrate flexibility and ability to embrace change. Adapt quickly to transformational and innovative conditions with a strong commitment to breakthroughs and development.
WuXi Vaccines established
A joint venture between WuXi Biologics and Shanghai Hile Bio-Technology
First contract signed
20-year supply of live-attenuated vaccine
First COVID-19 project signed
1st facility construction started in Ireland
Viral vector vaccine 30+ million doses delivered
Offer services on all five platforms
500+ MM doses delivered
38 projects from 17 clients
Contracted for global supply of another COVID-19 vaccine
Recognized as Best Vaccine CMO of the Year at the Asia-Pacific Vaccine Excellence Awards 2022
As an industry-leading CDMO for Global Vaccine Development and Manufacturing, WuXi Vaccines is committed to the highest standards of ethics and integrity. Employees, officers and directors strive to deal honestly, ethically and fairly with our suppliers, customers, competitors, employees and the communities we serve worldwide. Statements regarding the Company’s products and services must not be false, misleading, deceptive or fraudulent. WuXi Vaccines strives to conduct business with individuals and organizations who share our commitment to the highest ethical standards and who operate in a socially and environmentally responsible manner.
Intellectual Property Protection is the foundation of trust between WuXi Vaccines and our global customers. To that end, we have established the most stringent policies in China and in U.S. for the protection of intellectual property and for prosecution of IP violations.
WuXi Vaccines aligns to the rigorous and industry-leading IP protection policies of WuXi Biologics. Our purpose in business is to enable innovation for our global partners, who keep us at the top of their confidence. We guard IP protection with our founding principles of integrity, world-class security, zero-tolerance policies, and relentless pursuit of justice against any criminal act.